Advanced search
Publication Cover
Renal Failure Volume 25, 2003 - Issue 4
Submit an article Journal homepage
514
Views
13
CrossRef citations to date
0
Altmetric
CASE REPORT

Successful Management of Acute Renal Artery Thromboembolism by Intra-arterial Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator

Ben-Chung Cheng Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, R.O.C.
, M.D.,
Sheung-Fat Ko Department of Radiology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, R.O.C.
, M.D.,
Feng-Rong Chuang Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, R.O.C.
, M.D.,
Chih-Hsiung Lee Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, R.O.C.Correspondence[email protected]
, M.D.,
Jin-Bor Chen Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, R.O.C.
, M.D. &
Kuo-Tai Hsu Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, R.O.C.
, M.D.
Pages 665-670 | Published online: 07 Jul 2009

References

  • Hoxie H.J., Coggin C.B. Renal infarction. Statistical study of two hundred and five cases and detailed report of an unusual case. Arch. Int. Med. 1940; 65: 587–594
  • Ischemic renal disease. Oxford Textbook of Clinical Nephrology, 2nd Ed., M. Alex, J. Davison, C. Stewart, G. Jean-Pierre, N.S.K. David, R. Eberhard, G.W. Christopher. Oxford, New York 1998; Vol. 2: 1679–1688
  • Domanovits H., Paulis M., Nikfardjam M., Meron G., Kurkciyan I., Bankier A.A., Laggner A.N. Acute renal infarction. Clinical characteristics of 17 patients. Medicine. 1999; 78(6)386–394
  • John D.M., Chadalawada N.R., Warren C.W., Carl A.O. Conservative management of renal artery embolus. J. Urol. 1973; 109(2)138–143
  • Hamilton P.B., Phillips R.A., Hiller A. Duration of renal ischemia required to produce uremia. Am. J. Physiol. 1948; 109: 517–522
  • Lessman R.K., Johnson S.F., Coburn J.W., Kaufman J.J. Renal artery embolism: clinical features and long-term follow-up of 17 cases. Ann Intern. Med. 1978; 89(4)477–482
  • Gasparini M., Hofmann R., Stoller M. Renal artery embolism: clinical features and therapeutic options. J. Urol. 1992; 147(3)567–572
  • Verstraete M., Collen D. Pharmacology of thrombolytic drugs. J. Am. Coll. Cardiol. 1986; 8(6 suppl. B)33B–40B
  • Marder V.J., Sherry S. Thrombolytic therapy: current status. N. Engl. J. Med. 1988; 318(24)1512–1520, 1585–1595
  • Verstraete M., Bounameaux H., de Cock F., Van de Werf F., Collen D. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. J. Pharmacol. Exp. Ther. 1985; 235(2)506–512
  • Mügge A., Gulba D.C., Frei U., Wagenbreth I., Grote R., Daniel W.G., Lichtlen P.R. Renal artery embolism: thrombolysis with recombinant tissue-type plasminogen activator. J. Intern. Med. 1990; 228: 279–286
  • Collen D., Bounameaux H., De Cock F., Lijnen H.R., Verstraete M. Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction. Circulation 1986; 73(3)511–517
  • Krupski W.C., Feldman R.K., Rapp J.H. Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: preliminary report. J. Vasc. Surg. 1989; 10(5)491–500
  • The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N. Engl. J. Med. 1993; 329(9)673–682
  • Brott T.G., Haley E.C., Levy D.E., Jr., Barsan W., Broderick J., Sheppard G.L., Spilker J., Kongable G.L., Massey S., Reed R., Marler J.R. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992; 23(5)632–640

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.